Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guyan Liang

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Bioorganic & Medicinal Chemistry|March 23, 2005
Design, synthesis and characterization of a novel class of coumarin-based inhibitors of inducible nitric oxide synthaseSharon A Jackson, Sukhveen Sahni, Lan Lee, et al.
Journal of Medicinal Chemistry|February 21, 2003
Discovery of an orally efficacious inhibitor of coagulation factor Xa which incorporates a neutral P1 ligandYong Mi Choi-Sledeski, Robert Kearney, Gregory Poli, et al.
Bioorganic & Medicinal Chemistry|March 23, 2005
Structure based design of 4-(3-aminomethylphenyl)piperidinyl-1-amides: novel, potent, selective, and orally bioavailable inhibitors of betaII tryptaseJulian Levell, Peter Astles, Paul Eastwood, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Bioorganic & Medicinal Chemistry|March 23, 2005
Design, synthesis and characterization of a novel class of coumarin-based inhibitors of inducible nitric oxide synthaseSharon A Jackson, Sukhveen Sahni, Lan Lee, et al.
Journal of Medicinal Chemistry|February 21, 2003
Discovery of an orally efficacious inhibitor of coagulation factor Xa which incorporates a neutral P1 ligandYong Mi Choi-Sledeski, Robert Kearney, Gregory Poli, et al.
Bioorganic & Medicinal Chemistry|March 23, 2005
Structure based design of 4-(3-aminomethylphenyl)piperidinyl-1-amides: novel, potent, selective, and orally bioavailable inhibitors of betaII tryptaseJulian Levell, Peter Astles, Paul Eastwood, et al.
Pageof 2